Exelixis | Resultado Líquido



Net Income Alterar Data
Acadia Pharmaceuticals USD 18.99M 124.76M 2025-03
Agios Pharmaceuticals USD -89289000 7.23M 2025-03
Amgen USD 1.73B 1.1B 2025-03
AstraZeneca USD 2.92B 1.42B 2025-03
Bayer EUR 1.3B 1.63B 2025-03
BioMarin Pharmaceutical USD 185.69M 60.74M 2025-03
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Cytokinetics USD -161376000 11.36M 2025-03
Eisai JPY 949M 22.84B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Exelixis USD 159.62M 19.76M 2025-04
Genmab DKK 195M 3.65B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 158.2M 43.01M 2025-03
Ionis Pharmaceuticals USD -146938000 42.59M 2025-03
MacroGenics USD -15421000 71.73M 2024-12
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
Sanofi EUR 499M 2.32B 2024-12
Takeda JPY -103155000000 126.94B 2025-03
Ultragenyx Pharmaceutical USD -151080000 17.7M 2025-03
Xencor USD -53479000 8.34M 2024-12



Exelixis Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - May 2025.